Therapeutic safety and effectiveness of dual oral therapy with daclatasvir and asunaprevir for chronic HCV patients with renal dysfunction

Motoyuki Kohjima, Kenta Motomura, Toshimasa Koyanagi, Seiya Tada, Naoki Yamashita, Takeaki Sato, Syoji Nagase, Masaki Kato, Kazuhiro Kotoh, Makoto Nakamuta

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Fingerprint Dive into the research topics of 'Therapeutic safety and effectiveness of dual oral therapy with daclatasvir and asunaprevir for chronic HCV patients with renal dysfunction'. Together they form a unique fingerprint.

Medicine & Life Sciences